IQHQ Raises $900M of Capital in 2024 to Drive Continued Momentum

IQHQ, Inc. (“IQHQ” or “the Company”), a premier owner and developer of world-class life science districts, today announced that $900 million of new capital was raised in 2024, with the most recent closing occurring in December 2024.

“These capital rounds, which were led by existing institutional equity investors in IQHQ, demonstrate the long-standing conviction of IQHQ’s investors to its business and the robust outlook for life science real estate to create value for shareholders,” said Tyler Rose, IQHQ President and Chief Financial Officer. “Our proven ability to raise and allocate capital in the life science sector is a testament to the strength of IQHQ’s strategy, team, and projects that sit at the forefront of innovation.”

IQHQ’s districts are meticulously designed to provide best-in-class lab and research space with unparalleled amenities and easy access to transportation. The capital raise was supported by a strong year of leasing activity in 2024, having executed a total of 400,000 square feet of life science and retail leases through year-end. The new capital influx gives additional momentum to IQHQ’s business during a period of rapidly improving fundamentals for the life science sector, which has further increased the Company’s pipeline of active negotiations and prospects.

“Industry leaders are gravitating to our urban hubs of innovation which attract top talent and provide our partners with flexible research space to advance breakthroughs in health and technology,” said Stephen Rosetta, IQHQ Co-CEO and Co-Founder. “We intend to continue executing on key projects in the first quarter and are well-situated to build on our strategy throughout 2025 and beyond, further solidifying IQHQ’s position as the preeminent developer of world-class life science districts.”

View IQHQ >>